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Available online 2 June 2014AbstractThis study aimed to assess the impact of a multidisciplinary program of obesity treatment (MPOT) on adolescents who have maintained/
gained weight or lost weight. Eighty-six adolescents aged 10e18 years were allocated in either the intervention group (IG; n ¼ 44) or the control
group (CG; n ¼ 42). Each group was divided into two more groups: weight maintenance/gain and weight loss, as assessed after the intervention.
The MPOT lasted 16 weeks and was conducted by a multidisciplinary team based on cognitive-behavioral therapy. We analyzed body
composition and cardiometabolic parameters prior to and after the intervention. Adolescents from the IG who lost weight showed improvements
in maximal oxygen uptake (23.54  5.30 mL/kg/minute vs. 25.39  5.63 mL/kg/minute), body fat percentage (49.29  6.98% vs.
46.75  8.56%), triglyceride levels (116.58  46.50 mg/dL vs. 101.19  43.08 mg/dL), diastolic blood pressure (75.81  8.08 mmHg vs.
71.19  6.34 mmHg), and the number of risk factors for metabolic syndrome (2.00  1.06 vs. 1.58  1.10). Adolescents from the IG who
gained/maintained weight reported reduced body fat percentage (48.81  5.04% vs. 46.60  5.53%), systolic blood pressure
(123.39  14.58 mmHg vs. 115.83  7.02 mmHg), diastolic blood pressure (74.83  9.91 mmHg vs. 68.78  5.95 mmHg), and number of risk
factors for metabolic syndrome (from 1.67  1.09 to 1.11  0.68), and their lean mass (39.00  7.20 kg vs. 41.85  7.53 kg) and maximal
oxygen uptake (23.74  4.40 mL/kg/minute vs. 25.29  5.17 mL/kg/minute) increased in a manner similar to those of adolescents who lost
weight. Furthermore, we noted significant decreases in body mass index, body fat (kg), glycemia, and waist circumference in CG adolescents
who lost weight, whereas those in the CG who maintained/gained weight had an increase in body mass index, hip circumference, body fat (kg),
and lean mass. A 16-week MPOT promoted positive changes in body composition and cardiometabolic risk factors independently of weight
changes.
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Excess weight in children and adolescents is a growing
concern due to the elevated number of comorbidities [e.g.,
type 2 diabetes, hypertension, and metabolic syndrome
(MS)],1 which may develop at this time and may be present
later in adulthood.2 Thus, there is a need to developitness. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the
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population.3
Multidisciplinary interventions for obesity treatment in
children and adolescents have presented improvements in
anthropometric parameters, body composition, cardiorespira-
tory fitness, and cardiovascular risk factors such as MS and
dyslipidemia.4e7 Nevertheless, studies that did not show any
improvement in body weight are common.4,8,9 This may be in
part explained by the increase in lean body mass coupled with
the decrease in body fat mass observed following exercise
interventions,4,10 or possibly due to natural growth and
development that occur in adolescents.11 Therefore, it may be
suggested that weight loss should not be the only characteristic
to be assessed following lifestyle interventions, because many
other beneficial changes may occur. For instance, Masquio
et al12 found that adolescents who had small reductions in
body weight presented improvements in body mass index
(BMI), fat mass, visceral fat, lean mass, and waist circum-
ference (WC), whereas those who had small-to-moderate
weight loss also presented reductions in insulin resistance
and inflammatory markers following a 1-year multidisci-
plinary intervention. Wafa et al8 and Hughes et al9 noted
weight gain in children aged 5e11 years following a 6-month
lifestyle intervention. However, this weight gain was sub-
stantially less compared to the control group (CG), which
received nutritional advice only7 or no intervention.8
According to the Canadian Obesity Network,13 the success
in obesity treatment should be measured according to health
benefits and well-being, instead of the amount of weight lost.
However, to our knowledge, studies assessing the differential
effects of a multidisciplinary program for obesity treatment
(MPOT) in adolescents who gained or maintained weight after
the intervention period, compared to those who lost weight,
are scarce. Thus, the objective of the present study was to
assess differences in body composition, glucose, insulin, lipid
profile, and blood pressure in obese adolescents who gained/
maintained or lost body weight following an MPOT. It was
hypothesized that adolescents who took part in the MPOT
would see improvements in body composition, and metabolic
and hemodynamic parameters, irrespective of the amount of
weight lost.
MethodsParticipantsAdolescents and their families were recruited through
media advertisements. Ninety-seven obese adolescents took
part in this study. They were classified as obese according to
the cutoff points laid out by Cole et al14 and were invited to
participate in the MPOT in 2011 and 2012 through media
divulgation. Adolescents’ age varied from 10 years to 18
years.
We used the following inclusion criterion: concordance of
the adolescents and their parents/guardians in participating in
the MPOT. The exclusion criteria were as follows: endocrine
and metabolic diseases previously diagnosed and informed tothe pediatrician, long-term alcohol consumption, use of glu-
cocorticoids and psychotropics that could affect appetite
regulation, and <70% compliance in all multidisciplinary
interventions.
Adolescents who were not available to partake in the
intervention schedule (i.e., they were not able to participate in
all scheduled interventions, showed interest in the program
after it had already started, or their schedule did not match
with the schedule of the MPOT) were invited to be part of the
CG, and evaluated prior to and after the 16-week period. It is
important to note that none of these participants presented any
exclusion criteria and were thus eligible to take part in this
study. This is a pragmatic trial designed to evaluate the
effectiveness of interventions in real-life practice conditions.
Despite the disadvantage of not randomizing participants in
each group, as explanatory trials do (e.g., randomized
controlled trials), pragmatic trials produce results that can be
generalized and applied in routine practice settings.15,16
Fifty of the 97 adolescents initially evaluated were allo-
cated to the intervention group (IG) and 47 adolescents were
assigned to the CG. However, six adolescents from the IG and
five from the CG were excluded because they were unable to
complete the intervention due to transportation issues, pref-
erence for other activities in the same period, or demotivation
to continue in the MPOT, and/or they did not attend the last
assessment session. Thus, 86 adolescents completed the
protocol.
The MPOT lasted 16 weeks and was conducted twice a
year. The main objective of the intervention team (i.e., phys-
ical educators, nutritionists, psychologists, and a pediatrician)
was to aid in the establishment of eating and exercise behavior
changes based on cognitive-behavioral therapy. The psycho-
logical and nutritional intervention was held weekly, including
a 1-hour group meeting in each session. Physical educators
gave one 1-hour lecture per week and helped adolescents in
the IG take part in an exercise program three times per week,
with each session lasting 1 hour. The pediatrician set up in-
dividual appointments with each family (parents and adoles-
cents) to collect information that could help during treatment.
The protocol of the MPOT has been described in more detail
by Bianchini et al.4 The present study was approved by the
local Ethics Committee (protocol 463/2009) and is in accor-
dance with the guidelines of the Declaration of Helsinki.EvaluationDuring the week preceding the beginning of MPOT and the
week following its completion, adolescents took part in a
battery of assessments, which included body weight, stature,
BMI, WC, and hip circumference (HC) measurements. Body
weights of the participants, wearing light clothes and no shoes,
were measured on a Welmy scale (Welmy, Sa˜o Paulo, Brazil)
to the nearest 0.05 kg. Height was measured with a wall sta-
diometer to the nearest 0.1 cm. BMI was calculated as the
weight divided by height squared. WC and HC were measured
with a WISO tape (WISO, Santa Catarina, Brazil) to the
nearest 0.1 cm.
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Tanner stages.17 Adolescents identified themselves as being in
stage 1 were classified as prepubertal, stages 2 and 3 as pu-
bertal, and stages 4 and 5 as postpubertal.
Body composition was assessed by dual-energy X-ray ab-
sorptiometry (GE Healthcare Lunar enCORE, Denver, CO,
USA). The participants were evaluated during the afternoon,
while wearing light clothes and no metal objects. We
computed relative and absolute body fat mass and absolute
lean mass based on this assessment.Blood examinations, blood pressure, and
cardiorespiratory fitnessWe determined blood glucose, insulin, total cholesterol and
its fractions (high-density lipoprotein cholesterol, low-density
lipoprotein cholesterol, and very-low-density lipoprotein
cholesterol), triglyceride (TG) levels, systolic and diastolic
blood pressure (SBP and DBP), and maximal oxygen uptake
(VO2max) prior to and after the intervention.
Blood drawswere conducted by specialists fromanoutpatient
clinic during the morning following a 12-hour overnight fast
(Laboclin, Bahia, Brazil). MS was diagnosed according to the
International Diabetes Federation criteria.18 Five risk factors are
used to evaluate MS: TG levels 150 mg/dL; fasting glucose
100 mg/dL or a previous diagnosis of type 2 diabetes; SBP
130 mmHg and/or DBP85 mmHg; high-density lipoprotein
cholesterol <40 mg/dL in adolescents aged 10e16 years and
boys >16 years, and <50 mg/dL in girls >16 years; and WC
above the 90th percentile according to gender and age.19 If, at
least, three of these criteria are altered, including WC, MS is
considered to be present.
Dyslipidemia was considered to be present in cases where
one or more of the following variables were present: total
cholesterol 170 mg/dL, high-density lipoprotein cholesterol
<45 mg/dL, low-density lipoprotein cholesterol 130 mg/dL,
and TG levels 130 mg/dL. The cutoff points used were based
on the recommendations laid out in the I Brazilian guidelines
for the prevention of atherosclerosis in children and
adolescents.20
Insulin resistance and sensitivity were assessed by ho-
meostasis model assessment insulin-resistance index (HOMA-
IR) and quantitative insulin sensibility check index, respec-
tively. HOMA-IR was calculated according to the following
equation:
½blood fasting glucose ðmilligrams per deciliterÞ
 blood insulin ðin milliunits per literÞ=405:21 ð1Þ
Quantitative insulin sensibility check index was calculated
using the following formula:
1=ðlog insulin þ log blood glucoseÞ: ð2Þ
Insulin resistance was considered when HOMA-IR values
were 2.0.22
Blood pressure measurements were performed after 5e10
minutes of rest, using an automatic sphygmomanometer(Microlife, Aargau, Switzerland). We used the right arm for all
measurements, and all adolescents remained seated during
each measurement.
VO2max was determined indirectly with the Leger 20-m
multistage shuttle test.23,24 This is a maximal test initiated at
a speed of 8.5 km/hour, which progresses in increments of
0.5 km/hour each minute until the adolescents reach their
volitional exhaustion. Adolescents were guided by an audio
signal and an operator who helped them pace themselves.Statistical analysesWe used the ShapiroeWilk test for normality. Data were
presented as descriptive (means, standard deviation, and
relative frequency) and inferential (comparison between mo-
ments and groups) statistics. Chi-square test was used to
compare the prevalence of obesity, dyslipidemias, high blood
pressure, insulin resistance, and MS between sexes for all the
groups. Mixed repeated-measures analysis of covariance was
used to compare both assessments moments (pre and post-
intervention) in the weight gain/maintenance and weight loss
group for both IG and CG. We used the Tanner stage as a
covariate. Significance level was set at p < 0.05. Effect sizes
were calculated to determine the magnitude of the interven-
tion effect. Magnitudes of effect size were classified, ac-
cording to Cohen,25 as follows: 0.20 (trivial), between 0.21
and 0.50 (small), between 0.51 and 0.80 (moderate), and
>0.80 (large).
Results
From the 86 adolescents who completed the protocol, 44
adolescents (27 girls) were part of the IG and 42 adolescents
(21 girls) formed the CG. Each group was then divided into
two more groups: weight gain or maintenance (IGd18 ado-
lescents; CGd26 adolescents) and weight loss (IGd26 ado-
lescents; CGd16 adolescents).
The mean age of the IG adolescents at the beginning of the
intervention who gained/maintained body weight and those
who lost weight were 12.56  0.92 years and 12.92  2.00
years, respectively. In the CG, at the beginning of the inter-
vention, adolescents who gained/maintained weight and those
who lost weight were aged 13.65  2.00 years and
13.28  2.16 years, respectively. No differences in this vari-
able were observed between the four groups (p ¼ 0.249).
At baseline, 96.2% and 100% of the IG adolescents who
lost weight and gained/maintained weight, respectively, were
obese. The CG adolescents who lost weight and gained/
maintained weight (87.5% and 84.6%, respectively) were
obese. In IG adolescents, the prevalence of dyslipidemias was
80.8% in those who lost weight and 72.2% in those who
gained/maintained weight. In the CG adolescents who lost
weight and gained/maintained weight, the prevalence of dys-
lipidemias was 81.3% and 69.2%, respectively. As for high
blood pressure, the prevalence at baseline was 24.5%, 27.8%,
37.5%, and 34.6% in IG adolescents who lost weight, IG ad-
olescents who gained/maintained weight, CG adolescents who
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weight, respectively.
The prevalence of insulin resistance (according to HOMA-
IR) was 88.5%, 83.3%, 93.8%, and 92.3% in IG adolescents
who lost weight, IG adolescents who gained/maintained
weight, CG adolescents who lost weight, and CG adolescents
who gained/maintained weight, respectively. Finally, the fre-
quency of adolescents with MS was 23.1%, 22.2%, 25.0%,
and 19.2% in IG adolescents who lost weight, IG adolescents
who gained/maintained weight, CG adolescents who lost
weight, and CG adolescents who gained/maintained weight,
respectively.
No sex differences were observed in body composition
(absolute and relative body fat mass, and absolute lean mass)
and in the prevalence of obesity, dyslipidemias, high blood
pressure, insulin resistance, and MS (p  0.05) among all the
groups.
Anthropometric, cardiorespiratory fitness, and body
composition parameters prior to and after 16 weeks of inter-
vention, according to changes in body weight, are presented in
Table 1.
Discussion
The objective of the present study was to assess potential
differences in health parameters measured at baseline and
following a 16-week MPOT intervention in adolescents, based
on the weight gain/maintenance or weight loss following the
program.
The main finding of the present study is that the MPOTwas
able to improve significantly the BMI, BMI z score, HC,
VO2max, percentage and absolute body fat, TG levels, DBP,
WC, and number of risk factors for MS in adolescents who
lost weight. Conversely, IG adolescents who gained/main-
tained weight reported reduced relative and absolute body fat,
SBP, DBP, WC, and number of risk factors for MS; their lean
mass and VO2max increased in a manner similar to those of
adolescents who lost weight. Furthermore, we noted signifi-
cant decreases in BMI, BMI z score, body fat (kg), glycemia,
and WC in CG adolescents who lost weight, and increases in
BMI, HC, body fat (kg), and lean mass in CG adolescents who
gained/maintained weight.
Improvements in anthropometric, body composition, and
cardiorespiratory fitness variables, as well as cardiovascular
risk factors (e.g., type 2 diabetes, hypertension, and MS)
following short-term lifestyle interventions in overweight and
obese adolescents have been noted previously.4e7,26 However,
studies that assessed the differential effects of an MPOT in
adolescents who gained or maintained weight after the inter-
vention period, compared to those who lost weight, are scarce.
For the results on body composition, IG adolescents who
gained/maintained their body weight had improved lean mass
but reduced absolute and relative body fat mass, which ex-
plains, in part, the overall lack of weight loss observed post-
intervention. Covariance analysis showed that these improve-
ments, except for absolute body fat, were not influenced by the
Tanner pubertal stage. Thus, it is suggested that theintervention utilized was mainly responsible for these im-
provements, although natural growth and development might
also have played a role.11
Certain studies recommend that weight maintenance or
modest weight loss should be seen as a primary endpoint when
assessing the effects of lifestyle interventions in pediatric
populations.27e30 However, according to Wafa et al,8 Hughes
et al,9 and Oude Luttikhuis et al,31 most pediatric patients
cannot even maintain weight or achieve modest weight loss
after short-term interventions. Wafa et al8 evaluated 34 chil-
dren during a 6-month intervention, but only nine maintained
or lost weight following this intervention.
Considering the necessity of creating goals for obesity
control during intervention programs, Masquio et al12
demonstrated that improvements in inflammatory state and
insulin resistance were observed in adolescents (mean age
16.7  1.6 years) who presented low-to-moderate weight loss
(7.64%) after 1 year of a multidisciplinary intervention. As
weight loss increased (12.10% to 19.39%), the adolescents
also presented improvements in lipid profile, SBP, and DBP.
However, it is important to point out that the adolescents
assessed by Masquio et al12 were in the postpubertal stage, so
changes in body weight might have played a more important
role in the control of risk factors related to obesity, which is
also observed in adults.32,33
Reinehr et al34 verified the effects of a multidisciplinary
program based on lifestyle modifications in obese adolescents
(aged 9e13 years) and noted that those who lost weight also
presented improvements in TG levels, SBP, DBP, insulin
resistance, and high-sensitive C-reactive protein. However, no
changes were observed in adolescents who gained or main-
tained body weight. Nevertheless, the authors observed that
high-sensitive C-reactive protein showed a decreasing ten-
dency in adolescents who gained or maintained weight [from
1.3 mg/L (0.9e3.3 mg/L) to 0.6 mg/L (0.4e4.7 mg/L)],
indicating improvement in inflammatory state. This improve-
ment was explained by the association between physical ac-
tivity practice and lower high-sensitive C-reactive protein
levels.34,35
Ford et al36 proposed a cutoff point based on the BMI z
score in their study, which assessed 88 adolescents with a
mean age of 12.4 years (range 9.1e17.4 years) during a 1-year
multidisciplinary intervention focused on behavioral changes.
These authors observed that a decrease of 0.25 in BMI z scores
resulted in significant decreases in body fat, SBP, DBP, and
TG levels. In addition, reductions of at least 0.5 in BMI z
scores promoted even greater benefits in these variables.
However, in the present study, IG adolescents who gained/
maintained their body weight did not present improved BMI z
scores, despite presenting improvements in other parameters.
In relation to changes in cardiovascular risk factors after a
multidisciplinary intervention, we noted that adolescents who
gained/maintained or lost weight showed improvements in
DBP, WC, and the number of risk factors for MS. This last
parameter presented a higher effect size for adolescents who
gained/maintained weight (moderate), compared to those who
lost weight (small). Moreover, those who lost weight during
Table 1
Anthropometric, cardiorespiratory fitness, and body composition parameters assessed before and after 16 weeks of MPOT according to changes in body weight (body weight loss and body weight gain/
maintenance).
Variable Body weight loss Body weight gain or maintenance
Intervention group (n ¼ 26) Control group (n ¼ 16) Intervention group (n ¼ 18) Control group (n ¼ 26)
Baseline Post-16 wk ES Baseline Post-16 wk ES Baseline Post-16 wk ES Baseline Post-16 wk ES
Weight (kg) 85.01  15.25 82.77  14.70 a 0.15
(trivial)
86.84  21.46 85.43  21.75a 0.06 (trivial) 79.92  12.23 82.31  12.28a 0.20
(trivial)
83.30  15.61 86.14  16.17a 0.09
(trivial)
Height (m) 1.60  0.08 1.62  0.08a 0.25
(small)
1.64  0.12 1.65  0.12a 0.08 (trivial) 1.62  0.10 1.64  0.09a 0.21
(small)
1.64  0.08 1.65  0.08a 0.13
(trivial)
BMI (kg/m2) 33.03  5.20 31.67  5.41a 0.26
(small)
31.89  4.75 30.96  4.74a 0.20 (trivial) 30.37  2.77 30.69  3.20 0.11
(trivial)
30.95  3.87 31.49  4.11a 0.14
(trivial)
BMI z score 4.03  1.83 3.58  1.85a 0.25
(small)
3.72  1.36 3.37  1.31a 0.26 (small) 3.53  0.93 3.63  1.07 0.11
(trivial)
3.36  1.31 3.51  1.38 0.11
(trivial)
HC (cm) 113.44  10.24 110.39  10.23 a,b 0.30
(small)
110.76  11.36 110.31  11.20 0.04 (trivial) 108.77  7.69 107.89  6.72 e0.11
(trivial)
108.90  11.30 111.60  9.77a 0.26
(small)
VO2max (mL/kg/min) 23.54  5.30 25.39  5.63a 0.34
(small)
22.80  2.39 24.03  2.16 0.54 (moderate) 23.74  4.40 25.29  5.17a 0.32
(small)
25.39  4.58 24.77  4.24 0.14
(trivial)
Body fat (%) 49.29  6.98 46.75  8.56a 0.33
(small)
46.44  4.66 45.47  4.52 0.21 (small) 48.81  5.04 46.60  5.53a 0.42
(small)
45.89  6.97 46.00  7.40 0.02
(trivial)
Body fat (kg) 40.33  10.33 37.20  10.74a 0.30
(small)
38.40  9.28 37.06  9.84a 0.14 (trivial) 37.36  7.42 36.52  7.24 a,b 0.11
(trivial)
36.90  9.79 38.21  10.60a 0.13
(trivial)
Lean mass (kg) 40.83  7.65 41.48  7.60 0.09
(trivial)
44.58  12.66 44.58  12.61 0.00 (trivial) 39.00  7.20 41.85  7.53a 0.39
(small)
42.75  8.10 44.02  8.47a 0.15
(trivial)
BMI ¼ body mass index; ES ¼ effect size; HC ¼ hip circumference; MPOT ¼ multidisciplinary program for obesity treatment; VO2max ¼ maximal oxygen uptake.
Metabolic parameters, blood pressure, and WC prior to and after 16 weeks of intervention, according to changes in body weight, are presented in Table 2.
a Significant difference from the baseline within group.
b Effect of covariate Tanner stage.
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Table 2
Metabolic parameters, blood pressure, and WC before and after 16 weeks of MPOT according to changes in body weight (body weight loss and body weight gain or maintenance).
Variable Body weight loss Body weight gain or maintenance
Intervention group (n ¼ 26) Control group (n ¼ 16) Intervention group (n ¼ 18) Control group (n ¼ 26)
Baseline Post-16 wk ES Baseline Post-16 wk ES Baseline Post-16 wk ES Baseline Post-16 wk ES
Glycemia
(mg/dL)
86.58  9.37 89.08  9.67 0.26
(small)
87.56  8.47 83.06  7.55a 0.56
(moderate)
88.78  5.29 85.61  5.99 0.56 (moderate) 88.50  6.95 86.00  7.35 0.35
(small)
Insulin
(mg/dL)
20.30  7.97 17.97  9.76b 0.26
(small)
16.93  6.13 16.64  6.71 0.05
(trivial)
17.49  8.42 18.57  12.90 0.10 (trivial) 20.45  9.95 23.94  14.18 0.29
(small)
HOMA-IR 4.42  1.95 4.02  2.33b 0.19
(trivial)
3.69  1.50 3.47  1.52 0.15
(trivial)
3.88  2.02 3.92  2.73 0.02 (trivial) 4.47  2.23 5.21  3.51 0.26
(small)
QUICKI 0.315  0.028 0.320  0.028 0.18
(trivial)
0.320  0.020 0.323  0.023 0.14
(trivial)
0.319  0.022 0.320  0.022 0.05 (trivial) 0.313  0.021 0.307  0.019 0.30
(small)
TC (mg/dL) 156.81  23.83 151.08  24.93 0.24
(small)
161.63  28.95 159.31  32.11 0.08
(trivial)
164.94  32.02 160.72  30.14 0.14 (trivial) 166.04  28.93 164.04  32.25 0.07
(trivial)
TG (mg/dL) 116.58  46.50 101.19  43.08a 0.34
(small)
104.13  37.90 102.50  33.60 0.05
(trivial)
108.90  42.89 116.33  77.33 0.12 (trivial) 115.50  54.85 128.73  58.01 0.23
(small)
LDL-c
(mg/dL)
88.21  24.62 86.79  24.60 0.06
(trivial)
96.55  23.34 96.19  24.24 0.02
(trivial)
92.61  21.40 87.68  22.47 0.22 (trivial) 96.87  21.61 90.92  31.48 0.22
(small)
HDL-c
(mg/dL)
45.35  9.03 44.27  7.89 0.13
(trivial)
45.06  8.72 42.63  6.34 0.32
(small)
50.33  10.13 49.72  10.95 0.06 (trivial) 46.08  11.73 44.92  9.89 0.11
(trivial)
VLDL-c
(mg/dL)
23.06  9.29 20.69  8.65 0.26
(small)
18.33  8.56 20.50  6.72 0.28
(small)
21.78  8.59 23.27  15.55 0.12 (trivial) 23.10  10.97 25.75  11.61 0.23
(small)
SBP (mm/Hg) 122.58  17.42 121.23  9.22 0.10
(trivial)
129.00  13.68 125.94  11.42 0.24
(small)
123.39  14.58 115.83  7.02a 0.07 (trivial) 124.38  12.71 126.69  13.19 0.18
(trivial)
DBP (mm/Hg) 75.81  8.08 71.19  6.34a 0.64
(moderate)
76.31  15.66 75.06  11.05 0.09
(trivial)
74.83  9.91 68.78  5.95a 0.76 (moderate) 72.73  7.50 73.96  10.21 0.14
(trivial)
WC (cm) 92.77  10.13 89.97  10.78a,b 0.27
(small)
92.58  9.62 89.41  9.76a 0.33
(small)
90.11  6.79 88.11  5.92a 0.31 (small) 91.91  10.16 92.16  8.96 0.03
(trivial)
Risk factors
Dyslip (n)
1.27  0.87 1.08  0.98 0.21
(small)
1.13  0.89 1.44  0.89 0.35
(small)
1.11  0.90 1.06  0.87 0.06 (trivial) 1.23  1.14 1.42  0.95 0.18
(trivial)
Risk factors
MS (n)
2.00  1.06 1.58  1.10a 0.39
(small)
1.81  1.17 1.88  0.81 0.07
(trivial)
1.67  1.09 1.11  0.68a 0.63 (moderate) 1.69  1.19 1.92  1.20 0.19
(trivial)
DBP ¼ diastolic blood pressure; Dyslip ¼ dyslipidemias; ES ¼ effect size; HDL-c ¼ high-density lipoprotein cholesterol; HOMA-IR ¼ homeostasis model assessment insulin-resistance index; LDL-c ¼ low-
density lipoprotein cholesterol; MPOT ¼ multidisciplinary program for obesity treatment; MS ¼ metabolic syndrome; QUICKI ¼ quantitative insulin sensibility check index; SBP ¼ systolic blood pressure;
TC ¼ total cholesterol; TG ¼ triglyceride; VLDL-c ¼ very-low-density lipoprotein cholesterol; WC ¼ waist circumference.
a Significant difference from the baseline within group.
b Effect of covariate Tanner stage.
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gained/maintained weight had decreased SBP. These results
seem to be associated with the regular practice of exercise,
which improves blood pressure and lipid profiles,37 consid-
ering that CG adolescents, even those who lost weight, did
not have improvements in these same variables. Although we
did not assess eating habits, we presume that cognitive-
behavioral therapy contributed to changes in eating habits
as well.38 Furthermore, our exercise intervention combines
aerobic and resistance training, which was shown to be even
more efficient than only aerobic exercise in reducing risk
factors for MS.10
One factor that can be associated with the improvements in
cardiovascular risk factors is the increase in cardiorespiratory
fitness. Nassis et al39 reinforced that adolescents who presented
better levels of cardiorespiratory fitness also presented lower
cardiovascular risk, independently of BMI. These positive
changes in cardiorespiratory fitness are particularly important in
IG adolescents who gained/maintained body weight, because it
is expected that relative VO2max decreases as weight increases.
In the present study, however, cardiorespiratory fitness was
improved in the adolescents of the IG group, despite increases or
no change in body weight. The practice of exercise and physical
activity, especially activities involving greater muscle groups
(e.g., jogging, playing basketball) may have contributed to this
decrease in body fat, increase in lean mass, and improvement in
cardiorespiratory fitness.
These results show the importance of participating in a
multidisciplinary intervention for obese adolescents, rein-
forcing that these adolescents can achieve positive results for
their health irrespective of their success in short-term weight
loss. Freedhoff and Sharma40 developed a practical guide to
obesity management, which discusses the importance of
achieving quality-of-life or health-based goals that can be
reached within a reasonable time span. For example, the goal
for one adult can be to walk a few blocks to work, whereas for
another it can be to reduce the need for blood pressure
medication. According to the authors, these objectives can be
achieved through improvement in physical fitness40 alone,
independently of changes in body weight. Freedhoff and
Sharma40 stated that success in treatment approaches should
be measured on the basis of the achievement of these goals,
instead of the amount of weight lost.
These ideas and practices should also be applied to ado-
lescents, especially because adolescents are experiencing
natural growth and development,11 which naturally increases
their height, weight, and BMI14. Improvements noted in the
present study (e.g., cardiorespiratory fitness, body composi-
tion, blood pressure, and metabolic parameters) are mainly
associated with the practice of physical activity combined with
nutritional- and psychological-based intervention programs,
and are independent of the changes in body weight. Exercise,
especially the combination of aerobic and resistance-based
exercises, leads to an improvement in resting energy expen-
diture and help improve lipid oxidation.41 Although we did not
measure the resting metabolic rate, adolescents had an in-
crease in lean body mass, which is the primary determinant ofchanges in the resting energy expenditure.42 Moreover, as
previously mentioned, the improvements in VO2max may also
be associated with the positive changes in health parameters
assessed in the present study.
Thus, it seems necessary to consider other success criteria
during intervention programs to treat obese adolescents that
take into account not only body weight, but also body
composition, cardiorespiratory fitness, and hemodynamic and
metabolic parameters.31
In summary, the present study demonstrated that a 16-week
MPOT promoted positive changes in body composition, he-
modynamic parameters, cardiorespiratory fitness, and risk
factors for MS in adolescents who lost weight or gained/
maintained weight. Although some studies propose that suc-
cess in a short-term intervention is based on changes in body
weight and BMI measurements, we suggest the need for future
short-term programs to also consider changes in body
composition, cardiorespiratory fitness, and hemodynamic and
metabolic parameters, as these are crucial markers of impor-
tant health modifications.
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